JPML Centralizes Glucosamine False Ad Suits

Law360, New York (December 19, 2013, 5:25 PM EST) -- The U.S. Judicial Panel on Multidistrict Litigation centralized three suits in Maryland federal court on Tuesday that accuse Cosamin supplement manufacturer Nutramax Laboratories Inc. of exaggerating the glucosamine-based capsules’ power to protect damaged cartilage in consumers with arthritis.

The panel allowed the bid by Maryland-based Nutramax to centralize the litigation in Maryland, finding among other things that important documents and witnesses were likely to be found in the district, given Nutramax’s headquarters there. The panel also noted that the cases involve common factual questions, and said...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.